Special Issue "Reactive Oxygen Species-Based Dynamic Therapy of Cancer"
Deadline for manuscript submissions: closed (31 July 2023) | Viewed by 9986
Interests: photothermal therapy; photodynamic therapy; sonodynamic therapy; chemotherapy; cancer theranostics
Interests: nanomedicine; biomaterials
Reactive oxygen species (ROS)-related therapies by in situ ROS generation are emerging as an attractive therapeutic modality with potential to treat deep-seated tumors, avoiding side effects to healthy tissues. Nanomedicine, which can be designed with unique physicochemical properties, can respond to external excitations such as near-infrared (NIR) light, ultrasound (US), X-ray, and microwave (MW), or trigger internal chemical/biological reaction in tumor region to produce ROS for ROS-related therapies, showing great advantages for deep-seated tumor treatment with high specificity, safety, and non-invasiveness.
Although ROS-related therapies have made positive progress in tumor treatment, there are still many limitations. In this research topic, we aim to cover the latest research on functional biomaterials with unique capabilities for ROS-related cancer therapy
We cordially welcome investigators to submit articles (original research, review). Potential topics include, but are not limited to:
- Design and preparation of functional biomaterials for ROS-related cancer therapy;
- Killing mechanism of ROS-related therapy;
- Toxicology studies on ROS-induced biomaterials.
Dr. Xianwen Wang
Dr. Daoming Zhu
Dr. Zhijin Fan
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
- reactive oxygen species
- cancer therapy
- photodynamic therapy
- sonodynamic therapy
- chemodynamic therapy
- tumor microenvironment